Ty C. Akkoyun

• Cobepa SA, an independent, privately held investment company, on its investment in Ned’s Home, Ned’s Home’s acquisitions of A1 Exterminators and Go Green Lawn and Pest, its investment in Reaction Biology Corporation, and Reaction Biology Corporation’s acquisitions of vivoPharm LLC and Bioassay.
• Elevance Health, Inc., formerly Anthem, Inc., on its strategic partnership with Clayton, Dubilier & Rice to accelerate innovation in primary care delivery, enhance the healthcare experience, and improve health outcomes.
• CVC Capital Partners on the sale of its portfolio company Alvogen, a leading generic pharmaceutical company, to Lotus Pharmaceutical Co., Ltd.
• I Squared Capital, an independent global infrastructure investment manager, on its acquisition of Priority Power Management, LLC, an energy management services and infrastructure consulting firm, and its growth capital investment in RPower LLC, a distributed energy resource platform.
• Qatar Investment Authority, the sovereign wealth fund of the State of Qatar, on its minority investment in Kokusai Electric Corporation, a specialist manufacturer of semiconductor equipment based in Japan, and on various co-investments with market-leading U.S. private equity sponsors.
• Morgan Stanley Infrastructure Partners on the sale of its ownership stake in Seven Seas Water Group to EQT Infrastructure.
• The transaction committee of the board of directors of DigitalBridge Group, Inc. on the company’s sale to SoftBank Group Corp. for a total enterprise value of approximately $4 billion.
• Quikrete Holdings, Inc., the largest manufacturer of packaged concrete and cement mixes in the United States and Canada, on its $2.74 billion acquisition of Forterra, Inc., a Nasdaq-listed manufacturer of water and drainage infrastructure pipe and products.
• Ripple Fiber, a fiber optic internet provider based in Charlotte, North Carolina, on its partnership with Post Road Group, an alternative investment firm focused on digital infrastructure and real estate.
• Fisk Alloy, Inc., a U.S.-based manufacturer of copper alloy wires, on its agreement to be acquired by Thermo Technologies, an affiliate of Edify SA, a Swiss industrial holding company listed on the Euro-MTF market of the Luxembourg Stock Exchange.
• AMETEK, Inc., a leading global provider of industrial technology solutions, on its acquisitions of Magnetrol International and Crank Software.
• Bryan, Garnier & Co., a leading independent full-service investment bank specializing in the European technology and healthcare sectors, on its acquisition by Stifel Financial Corp.
• Doha Venture Capital, the global venture capital arm of the Qatar Free Zone Authority, on its investment in and partnership with AeroFarms, a U.S.-based Certified B Corporation and leader in indoor vertical farming.
• Dogwood Energy, LLC on the sale of an undivided interest in the Dogwood Energy Facility, a 650 MW natural gas combined cycle facility located in Pleasant Hill, Missouri, to Evergy Missouri West, Inc.
• Lordstown Motors Corp., an electric vehicle manufacturer, on the sale of its manufacturing assets to LAS Capital pursuant to Section 363 of the Bankruptcy Code.
• MNG Havayollari Ve Tasimacilik A.S., a global logistics provider and e-commerce enabler, on its terminated business combination agreement with Golden Falcon Acquisition Corp. for a pro forma enterprise value of $676 million.
• Falcon’s Beyond, a global entertainment development company, on its $1 billion merger agreement with FAST Acquisition Corp. II.
• Milestone Partners on its investments in Cypress Group Holdings, Inc. and StrucSure Home Warranty.
• Champlain Capital on its acquisition of Pelton Shepherd, a privately held manufacturer of gel ice refrigerants.
• Susquehanna Private Capital on its investment in College Hunks Hauling Junk & Moving.
• Susquehanna Growth Equity on its Series B growth round investment in ActiveCampaign.
• Companion Spine and Viscogliosi Brothers, LLC on the acquisition of spinal assets from Medtronic.
• Ensysce Biosciences, Inc., a clinical-stage biotech company, on its business combination with Leisure Acquisition Corp.
• Interpace Biosciences, Inc. on its acquisition of the biopharma business of Cancer Genetics, Inc. pursuant to a UCC Article 9 foreclosure sale and the related investment by Ampersand Capital Partners in convertible preferred stock of Interpace.
• Adit EdTech Acquisition Corp., a special purpose acquisition company, on its $276 million initial public offering on the New York Stock Exchange.

Includes representations prior to Ty’s association with Broadfield.

• New York